secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000950170-24-122229
Event type: earnings
Sentiment:  neutral
Materiality: 0.72
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q3 revenue $28.7M, net loss $0.55/share; raises FY2024 revenue guidance to ~$112M
--------------------------------------------------------------------------------

- Revenue $28.7M down 6% YoY but up 5% QoQ; product revenue $20.3M down 14% YoY.
- Recurring revenue (cartridges + service) $21M, up 17% YoY; gross margin 34.3% vs 23.6% YoY.
- Net loss $27.9M ($0.55/share) vs $46.2M ($0.93/share) in Q3 2023; non-GAAP net loss $20.2M ($0.39/share).
- FY2024 revenue guidance raised to ~$112M from ~$110M; non-GAAP gross margin guided to mid-30% range.
- Cash & investments $179.0M as of Sept 30, 2024; operating expenses down 36% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/0000950170-24-122229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/om-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer